Concepedia

G. Wei Xu

GW

Statistics

Publications

6

Citations

379

H-Index

6

Active since

2010

Affiliations

Princess Margaret Cancer Centre(Current)

University of Toronto

Ontario Institute for Cancer Research

University Health Network

Sanford Burnham Prebys Medical Discovery Institute

G. Wei Xu is an author at Princess Margaret Cancer Centre specializing in molecular biology, mitochondrial biology, and enzyme inhibition.

ORCID

Publications per year

2010–2024

6

Publications

6

The ubiquitin-activating enzyme E1 as a therapeutic target for the treatment of leukemia and multiple myeloma

G. Wei Xu, Mohsin Ali, Tabitha E. Wood et al. · Blood · 2010 · 169 citations · Full text

, , +16

The Mitochondrial Transacylase, Tafazzin, Regulates AML Stemness by Modulating Intracellular Levels of Phospholipids

Ayesh K. Seneviratne, Mingjing Xu, Juan J. Aristizabal Henao et al. · Cell stem cell · 2019 · 59 citations · Full text

, , +16

Mutations in UBA3 Confer Resistance to the NEDD8-Activating Enzyme Inhibitor MLN4924 in Human Leukemic Cells

G. Wei Xu, Julia I. Toth, Sara R. da Silva et al. · PLoS ONE · 2014 · 43 citations · Full text

, , +12

Identification of NAE Inhibitors Exhibiting Potent Activity in Leukemia Cells: Exploring the Structural Determinants of NAE Specificity

Julie L. Lukkarila, Sara R. da Silva, Mohsin Ali et al. · ACS Medicinal Chemistry Letters · 2011 · 41 citations

, , +13

Mitochondrial carrier homolog 2 is necessary for AML survival

Dilshad H. Khan, Michael Mullokandov, Yan Wu et al. · Blood · 2020 · 34 citations · Full text

, , +5

1–5 of 6